Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024

11 Feb 2025

Abstract excerpt

Objective In January 2023, China implemented the “Class B Management” policy, marking a new phase in COVID-19 control. As new SARS-CoV-2 variants continue to emerge, some have shown significant immune evasion, posing challenges to epidemic control efforts. To manage the pandemic effectively, Henan Province launched a surveillance program for SARS-CoV-2 variants, systematically analyzing their clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40007604
DOI: 10.3389/fcimb.2025.1511114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024PMID 40007604Read ↗

Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysisSemantic proximity Read ↗

Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022Semantic proximity Read ↗

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021-2022.Semantic proximity Read ↗

Analysis of the transmission rate of SARS-CoV-2 Omicron subvariants BA.5.2 and BF.7 based on COVID-19 surveillance data.Semantic proximity Read ↗

Evolutionary analysis of Omicron variant BF.7 and BA.5.2 pandemic in ChinaSemantic proximity Read ↗

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variantSemantic proximity Read ↗

Tracking SARS-CoV-2 Evolution: Genomic Insights from Yantai, China in 2023Semantic proximity Read ↗

Epidemiological and Clinical Features of SARS-CoV-2 Omicron Variant Infection in China: A Retrospective StudySemantic proximity Read ↗

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity Read ↗

COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China.Semantic proximity Read ↗

Title of the article: Current Review of the SARS-CoV-2 Omicron Subvariant BF.7 (BA.5.2.1.7) Virology and Preventing Strategies.Semantic proximity Read ↗

COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: a prospective, comparative cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.